Concept Map on Toxic Stress in Newborns
Launched by ÇANKIRI KARATEKIN UNIVERSITY · May 16, 2024
Trial Information
Current as of July 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Concept Map on Toxic Stress in Newborns," is looking at how teaching methods can improve nursing students' understanding of a serious issue called toxic stress in newborns. Toxic stress refers to the overwhelming stress that can affect a baby's health and development. In this study, second-year nursing students will learn about this topic using a tool called concept maps, which help organize and understand complex information better.
To participate in this trial, students need to be currently enrolled in the course and have never taken it before. They also need to agree to be part of the research. However, students who have missed classes or have already completed this course, as well as those who graduated from a health vocational school, will not be eligible. The study is not yet recruiting participants, but once it starts, selected students can expect to engage in a learning experience that aims to enhance their knowledge and skills in caring for newborns facing toxic stress.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in the course
- • Had not taken this course before
- • Accepted to participate in the research
- Exclusion Criteria:
- • Have any records of absence
- • Taken this course before
- • Graduate of health vocational high school
About çankırı Karatekin University
Çankırı Karatekin University is a distinguished academic institution committed to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to enhance healthcare outcomes and contribute to the scientific community. Leveraging its state-of-the-art facilities and a network of experienced researchers, Çankırı Karatekin University fosters a rigorous research environment dedicated to exploring novel therapeutic approaches and improving patient care. The university's commitment to ethical standards and regulatory compliance ensures that all clinical trials conducted under its auspices uphold the highest levels of integrity and scientific excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported